The instructions have come into effect immediately and are mandatory for all CGHS Wellness Centres and empanelled healthcare organisations
Thyroid risk: Clinical studies showed a risk of thyroid tumours with semaglutide in animals
Side-by-Side Comparison of Nausea Management Methods The effectiveness of each approach can vary depending on how its implemented and individual responses
By activating GLP-1 receptors in the brain, these injections help control hunger and reduce calorie intake, leading to weight loss
Heres what the team at Southdowns commonly sees: Noticing several of these together is a signal worth acting on
By binding to GLP-1 receptors in the pancreas, brain, and gut, semaglutide: Stimulates insulin release only when blood glucose is elevated, which significantly reduces hypoglycaemia risk compared to older diabetes drugs Suppresses glucagon reducing the livers release of stored glucose into the bloodstream Slows gastric emptying food leaves the stomach more slowly, producing prolonged fullness and reducing overall caloric intake Acts on the brains appetite centres reducing hunger signals and food cravings Mounjaro (Tirzepatide): Dual GLP-1 + GIP Receptor Agonist Tirzepatide activates the same GLP-1 receptor as semaglutide but also activates a second receptor: the glucose-dependent insulinotropic polypeptide (GIP) receptor